'Pharma Bro' Wants Out of Jail To Research Coronavirus
Convicted former drug company CEO Martin Shkreli, best known before his arrest for drug price-gouging and his snarky online persona, wrote that his background "as a successful two-time biopharma entrepreneur, having purchased multiple companies, invented multiple new drug candidates" would make him a valuable asset.
April 09, 2020 at 12:14 PM
2 minute read
Convicted former drug company CEO Martin Shkreli, known as "Pharma Bro," wants to get out of prison so he can help research a treatment for the coronavirus, his lawyer said Tuesday.
Defense attorney Ben Brafman said that he will file court papers asking federal authorities to release Shkreli for three months so he can do laboratory work "under strict supervision."
His client—best known before his arrest for drug price-gouging and his snarky online persona—is housed at a low-security prison in Allenwood, Pennsylvania.
"I have always said that if focused and left in a lab, Martin could help cure cancer," Brafman said in a statement. "Maybe he can help the scientific community better understand this terrible virus."
In a research proposal posted online, Shkreli called the pharmaceutical industry's response to the pandemic "inadequate" and said researchers at every drug company "should be put to work until COVID-19 is no more."
Shkreli wrote that his background "as a successful two-time biopharma entrepreneur, having purchased multiple companies, invented multiple new drug candidates" would make him a valuable asset.
"I am one of the few executives experienced in ALL aspects of drug development," he said, adding, "I do not expect to profit in any way, shape or form from coronavirus-related treatments."
Shkreli, 37, was sentenced to seven years in prison 2018 for crimes that included lying to investors about the performance of two hedge funds he ran, withdrawing more money from those funds than he was entitled to get, and defrauding investors in a drug company, Retrophin, by hiding his ownership of some of its stock.
A judge ordered Shkreli to forfeit $7.3 million.
Shkreli first gained notoriety by buying the rights to a lifesaving drug at another company in 2014 and raising the price from $13.50 to $750 per pill.
He is also known for attacking critics on social media and offering a bounty to anyone who could give him one of Hillary Clinton's hairs.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllAttorneys 'On the Move': Structured Finance Attorney Joins Hunton Andrews Kurth; Foley Adds IP Partner
4 minute readNY Civil Liberties Legal Director Stepping Down After Lengthy Tenure
Former Top Aide to NYC Mayor Is Charged With Bribery Conspiracy
Trending Stories
- 1Call for Nominations: Elite Trial Lawyers 2025
- 2Senate Judiciary Dems Release Report on Supreme Court Ethics
- 3Senate Confirms Last 2 of Biden's California Judicial Nominees
- 4Morrison & Foerster Doles Out Year-End and Special Bonuses, Raises Base Compensation for Associates
- 5Tom Girardi to Surrender to Federal Authorities on Jan. 7
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250